5）抗好中球細胞質抗体（ANCA）関連血管炎の病態と治療の最前線
Saved in:
| Published in | 日本内科学会雑誌 Vol. 103; no. 9; pp. 2121 - 2129 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | Japanese |
| Published |
一般社団法人 日本内科学会
2014
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0021-5384 1883-2083 |
| DOI | 10.2169/naika.103.2121 |
Cover
| Author | 有村, 義宏 槇野, 博史 針谷, 正祥 藤井, 隆夫 山村, 昌弘 石津, 明洋 佐田, 憲映 |
|---|---|
| Author_xml | – sequence: 1 fullname: 針谷, 正祥 organization: 東京医科歯科大学大学院医歯学総合研究科薬害監視学講座 – sequence: 1 fullname: 槇野, 博史 organization: 岡山大学大学院医歯薬学総合研究科腎・免疫・内分泌代謝内科学 – sequence: 1 fullname: 藤井, 隆夫 organization: 京都大学大学院医学研究科リウマチ性疾患制御学講座 – sequence: 1 fullname: 石津, 明洋 organization: 北海道大学大学院保健科学研究院病態解析学分野 – sequence: 1 fullname: 佐田, 憲映 organization: 岡山大学大学院医歯薬学総合研究科腎・免疫・内分泌代謝内科学 – sequence: 1 fullname: 有村, 義宏 organization: 杏林大学第一内科学教室腎臓・リウマチ膠原病内科 – sequence: 1 fullname: 山村, 昌弘 organization: 岡山済生会総合病院リウマチ・膠原病センター |
| BookMark | eNo9kE1LAlEUhi9hkJnb_sXY_Zy5Lk36AqlNtR2uM3NrzCxm3LTzA0GLIgiSIgKLIIIkKihIf406V1f-hSaLeOG8vO85nMUzCyKFg4IDwDyCCYz05EJBuHsigSAJI0ZTIIo4JxqGnERAFEKMNEY4nQFx33ezkBKdcURoFGyzcacRHDcHD93-57M6r6r3l2H1dvj2FJb97sW4U0-tp1Ph0ejyblS6H7ZKqt1SlbNeua2ataB20is_Bq9f6qoSNsFNadA4VR_Xc2BairzvxP88BraWlzbTq1pmY2UtncpoOcSx0HjSyOqhhIGIZBYxmIE4FZbklnBsBoVE0CZQd6DNGEZcZg1MbVtCQjGn0iIxsPj7N-cXxY5jHnruvvCOTOEVXSvvmBMsZojFTE7mD5z_pbUrPDMnyDfI4nyW |
| ContentType | Journal Article |
| Copyright | 2014 一般社団法人 日本内科学会 |
| Copyright_xml | – notice: 2014 一般社団法人 日本内科学会 |
| DOI | 10.2169/naika.103.2121 |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1883-2083 |
| EndPage | 2129 |
| ExternalDocumentID | article_naika_103_9_103_2121_article_char_ja |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS DIK F5P JSF OK1 RJT |
| ID | FETCH-LOGICAL-j182a-897b6b6ba713f5c3757184acf8caed50af10d306e0d55218fb724ddf034284fc3 |
| ISSN | 0021-5384 |
| IngestDate | Wed Sep 03 06:30:14 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 9 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j182a-897b6b6ba713f5c3757184acf8caed50af10d306e0d55218fb724ddf034284fc3 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/naika/103/9/103_2121/_article/-char/ja |
| PageCount | 9 |
| ParticipantIDs | jstage_primary_article_naika_103_9_103_2121_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2014 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – year: 2014 text: 2014 |
| PublicationDecade | 2010 |
| PublicationTitle | 日本内科学会雑誌 |
| PublicationTitleAlternate | 日内会誌 |
| PublicationYear | 2014 |
| Publisher | 一般社団法人 日本内科学会 |
| Publisher_xml | – name: 一般社団法人 日本内科学会 |
| References | 16) Lapraik C, et al: BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 46: 1615-1616, 2007. 20) de Groot K, et al: Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150: 670-680, 2009. 15) Watts R, et al: Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66: 222-227, 2007. 1) Jennette JC, et al: 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11, 2013. 7) Nakazawa D, et al: Enhanced Formation and Disordered Regulation of NETs in Myeloperoxidase-ANCA-Associated Microscopic Polyangiitis. J Am Soc Nephrol 25: 990-997, 2014. 9) Falk RJ, Jennette JC: ANCA disease: where is this field heading? J Am Soc Nephrol 21: 745-752, 2010. 5) Ando M, et al: Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis. Respir Med 107: 608-615, 2013. 3) Tsuchiya N, et al: Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese. Genes Immun 7: 81-84, 2006. 19) Mukhtyar C, et al: Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68: 1827-1832, 2009. 13) Lyons PA, et al: Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367: 214-223, 2012. 10) Fujimoto S, et al: Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford) 50: 1916-1920, 2011. 24) Guerry MJ, et al: Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 51: 634-643, 2012. 18) Ozaki S, et al: Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol 22: 394-404, 2012. 23) Stone JH, et al: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363: 221-232, 2010. 22) Jones RB, et al: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363: 211-220, 2010. 8) Gadola SD, Gross WL: Vasculitis in 2011: the renaissance of granulomatous inflammation in AAV. Nat Rev Rheumatol 8: 74-76, 2012. 6) Kessenbrock K, et al: Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15: 623-635, 2009. 14) Millet A, et al: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Ann Rheum Dis 72: 1273-1279, 2013. 17) Mukhtyar C, et al: EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68: 310-317, 2009. 2) Chen M, Kallenberg CG: ANCA-associated vasculitides-advances in pathogenesis and treatment. Nat Rev Rheumatol 6: 653-664, 2010. 11) Sada KE, et al: Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 16: R101, 2014. 4) Pendergraft WF 3rd, et al: Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 10: 72-79, 2004. 12) Bonsal PJ, Tobin MC: Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93: 398-401, 2004. 21) Jayne DR, et al: Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18: 2180-2188, 2007. |
| References_xml | – reference: 2) Chen M, Kallenberg CG: ANCA-associated vasculitides-advances in pathogenesis and treatment. Nat Rev Rheumatol 6: 653-664, 2010. – reference: 10) Fujimoto S, et al: Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford) 50: 1916-1920, 2011. – reference: 5) Ando M, et al: Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis. Respir Med 107: 608-615, 2013. – reference: 18) Ozaki S, et al: Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol 22: 394-404, 2012. – reference: 22) Jones RB, et al: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363: 211-220, 2010. – reference: 1) Jennette JC, et al: 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11, 2013. – reference: 7) Nakazawa D, et al: Enhanced Formation and Disordered Regulation of NETs in Myeloperoxidase-ANCA-Associated Microscopic Polyangiitis. J Am Soc Nephrol 25: 990-997, 2014. – reference: 12) Bonsal PJ, Tobin MC: Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93: 398-401, 2004. – reference: 13) Lyons PA, et al: Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367: 214-223, 2012. – reference: 20) de Groot K, et al: Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150: 670-680, 2009. – reference: 3) Tsuchiya N, et al: Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese. Genes Immun 7: 81-84, 2006. – reference: 6) Kessenbrock K, et al: Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15: 623-635, 2009. – reference: 8) Gadola SD, Gross WL: Vasculitis in 2011: the renaissance of granulomatous inflammation in AAV. Nat Rev Rheumatol 8: 74-76, 2012. – reference: 19) Mukhtyar C, et al: Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68: 1827-1832, 2009. – reference: 23) Stone JH, et al: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363: 221-232, 2010. – reference: 17) Mukhtyar C, et al: EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68: 310-317, 2009. – reference: 9) Falk RJ, Jennette JC: ANCA disease: where is this field heading? J Am Soc Nephrol 21: 745-752, 2010. – reference: 4) Pendergraft WF 3rd, et al: Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 10: 72-79, 2004. – reference: 11) Sada KE, et al: Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 16: R101, 2014. – reference: 16) Lapraik C, et al: BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 46: 1615-1616, 2007. – reference: 24) Guerry MJ, et al: Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 51: 634-643, 2012. – reference: 14) Millet A, et al: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Ann Rheum Dis 72: 1273-1279, 2013. – reference: 21) Jayne DR, et al: Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18: 2180-2188, 2007. – reference: 15) Watts R, et al: Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66: 222-227, 2007. |
| SSID | ssib043658134 ssj0066765 ssib002821954 ssib005879745 ssib007485360 ssib058493862 ssib000940260 ssib002484664 |
| Score | 1.9588974 |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 2121 |
| SubjectTerms | ANCA関連血管炎 リツキシマブ 多発血管炎性肉芽腫症 好酸球性多発血管炎性肉芽腫症 顕微鏡的多発血管炎 |
| Title | 5）抗好中球細胞質抗体（ANCA）関連血管炎の病態と治療の最前線 |
| URI | https://www.jstage.jst.go.jp/article/naika/103/9/103_2121/_article/-char/ja |
| Volume | 103 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 日本内科学会雑誌, 2014/09/10, Vol.103(9), pp.2121-2129 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Na9RANJQK4kX8xG96cPAgqfmYJG_wNLNNKUoLQiu9LclucthDFWkvnvpBwSqKIFgUEaoIIlhEBQXbX9N2tz31L_jeTHaThR5svYTJy_t-mcybMPPGsq47zSilOul2GqaRzTEHsJM8FHbo5OClWZa4nDYnj0-EY1P8znQwPTB4o7JqaW42HW48PnBfyVGiijCMK-2SPURke0wRgG2ML14xwnj9pxgHLB5lqsZAsDhkIJmIWBwwGTA1wmLOFDCJjYgJh4FPDYVAh8VAtyKmhvKZlBVyTrTC73IGOVGTFTGCiZBJjxrgMOkTC-lSG7nLmNrYAI8BcvcxTyUgaYDAQIsJGKjuIyCI8phSGkcQYUkVMlHTnAMSDdoShWiymlFrtIhsNviypvG1IFIJ8V3tlBEmQ21eDTloQ5R-BGQ_9H4Wa8uQaEQ7xyGB-BYSc-KgnSjJxSV-SEKQxBBCbPADUpgEYQO955X4oPXlWhf0eWDwBSGj2qQqZ1KV-KjMKIWJXMVJeKGPAO1kDQVV_X3jlj9ui9cATNBBu0dLVzGJQh9Iw9knTYxKSt48mlerQ6Dn2jjKGUUyM-oB-NixzIlCvWHR8Sv9X_QNcmZTe5Ew4a04aDD23JBq2c7QVjiq7TBc0vUVOC-6T10j1hGxLvSV0Ovdh7QHsd7CidAxL4pcWrt7915lHiE41car5J3Qd2yCB55brXsYQCSqxzxEHLPWkp77mJe7Zd1ETNKFD2GvLh2tCzdHoxS-NNVgyeBb_eZiXtvCWV53hahOWidPWSeL2eaQNOadtgZayRnr-HixnuasdT_Y31hpP13d-bS5_ftr5-VS5-e33aX3uz--IHB789X-xhPq_4i09_rD3vzH3bX5zvpaZ_HF1sJ6Z3W5vfxsa-Fz-_ufzptFhLTfze-sPO_8envOmhqNJ2tjdnHSit1ywUtsEBF-q8M0iVw_Dxo-frxd4Ekjh0aSNQMnyV2n6Tth5jQDzPchTyOPN5s51Q8Fnjf889bgzIOZ7II11MAZQYqf_6aXRTxJhACnkbo8z70sQQelF63bxiP1h6acTv0w8b_0X9SXrRPUBc0f1CvW4Oyjuewqzilm02v6ffoLC6LmqQ |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=5%EF%BC%89%E6%8A%97%E5%A5%BD%E4%B8%AD%E7%90%83%E7%B4%B0%E8%83%9E%E8%B3%AA%E6%8A%97%E4%BD%93%EF%BC%88ANCA%EF%BC%89%E9%96%A2%E9%80%A3%E8%A1%80%E7%AE%A1%E7%82%8E%E3%81%AE%E7%97%85%E6%85%8B%E3%81%A8%E6%B2%BB%E7%99%82%E3%81%AE%E6%9C%80%E5%89%8D%E7%B7%9A&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E9%87%9D%E8%B0%B7%2C+%E6%AD%A3%E7%A5%A5&rft.au=%E6%A7%87%E9%87%8E%2C+%E5%8D%9A%E5%8F%B2&rft.au=%E8%97%A4%E4%BA%95%2C+%E9%9A%86%E5%A4%AB&rft.au=%E7%9F%B3%E6%B4%A5%2C+%E6%98%8E%E6%B4%8B&rft.date=2014&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=103&rft.issue=9&rft.spage=2121&rft.epage=2129&rft_id=info:doi/10.2169%2Fnaika.103.2121&rft.externalDocID=article_naika_103_9_103_2121_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon |